CYCLOPHARM LIMITED (CYC)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:

CYC - CYCLOPHARM LIMITED
FNArena Sector : Medical Equipment & Devices
Year End: December
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -0.68
Index:
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$2.05
26 May |
0.000 OPEN $2.09 |
0.000 HIGH $2.11 |
22,983 LOW $2.05 |
TARGET | |||||
|
|||||
Franking for last dividend paid out: 0% |
OTHER COMPANIES IN THE SAME SECTOR | |||
4DX . AHZ . AT1 . BRN . CAT . CBL . CGS . CMP . COH . CSX . CU6 . EBR . ELX . EMV . EYE . FPH . HLA . IDX . IME . IMR . IPD . LDX . LHC . MEB . MX1 . NAN . ONE . OVN . PCK . PEB . PGC . PME . RAP . RMD . RVA . SOM . TRJ . UBI . VHT . VTI . |
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY21 Actual |
FY22 Actual |
FY23 Forecast |
FY24 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | - 7.2 | - 6.5 | xxx |
DPS (cps) | xxx | N/A | 1.0 | xxx |
EPS Growth | xxx | N/A | N/A | xxx |
DPS Growth | xxx | N/A | N/A | xxx |
PE Ratio | xxx | N/A | N/A | xxx |
Dividend Yield | xxx | N/A | 0.5% | xxx |
Div Pay Ratio(%) | xxx | N/A | N/A | xxx |
Last ex-div: 04/09 - ex-div 0.5c (franking 0%)
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | -7.2 |
DPS All | xxx | xxx | xxx | xxx | xxx | 1.0 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 23.2 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 39.3 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | -6.7 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | -28.47 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | -16.61 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | -15.02 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | -12.56 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | -16.61 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | -16.46 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | -8.8 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 0 M |
Long Term Debt | xxx | xxx | xxx | xxx | xxx | 4 M |
Total Debt | xxx | xxx | xxx | xxx | xxx | 4 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | - |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 20 M |
Price To Book Value | xxx | xxx | xxx | xxx | xxx | 2.98 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross

Cash & Equivalents - Generic
Price To Book Value
Title | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | xxx | 1.5 M |
Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 6.67 % |
Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 17 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 13 M |
Research & Development | xxx | xxx | xxx | xxx | xxx | 3 M |
Investments - Total | xxx | xxx | xxx | xxx | xxx | - |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
CYC STOCK CHART

FNArena News on CYC
Latest Medical Equipment & Devices News
1 |
Dr Boreham’s Crucible: ImpedimedMay 08 2023 - Small Caps |
2 |
Treasure Chest: ResMed’s Benevolent MonopolyMay 01 2023 - Treasure Chest |
3 |
Dr Boreham’s Crucible: Volpara Health TechnologiesApr 26 2023 - Small Caps |
4 |
Dr Boreham’s Crucible: SDIMar 16 2023 - Small Caps |
5 |
Dr Boreham’s Crucible: CochlearMar 03 2023 - Australia |
6 |
Dr Boreham’s Crucible: Imagion BiosystemsFeb 13 2023 - Small Caps |
7 |
ResMed: Philips Remains The Big UnknownJan 31 2023 - Australia |
8 |
Nanosonics Outlook Remains CloudedJan 24 2023 - Small Caps |
9 |
Nanosonics Recovers On Less Negative SentimentNov 29 2022 - Small Caps |
10 |
Treasure Chest: Fisher & Paykel HealthcareNov 16 2022 - Treasure Chest |